Commenting on the results for ESMO, Dr Evandro de Azambuja, Head of the Medical Support Team, Academic Promoting Team, Jules Bordet Institute, Brussels, Belgium, said: «This study shows that it's not
only tumour size that is important for breast cancer patients but also tumour biology.